BIODESIX, INC. Common Stock, Capital Shares Reserved for Future Issuance
BIODESIX, INC. (BDSX) had Common Stock, Capital Shares Reserved for Future Issuance of 49.64 thousand shares as of 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2025-11-03
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 49.64K shares.
- 2025-06-30: Common Stock, Capital Shares Reserved for Future Issuance 1.50M shares.
- 2025-03-31: Common Stock, Capital Shares Reserved for Future Issuance 48.50K shares.
- 2024-09-30: Common Stock, Capital Shares Reserved for Future Issuance 175.28K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-09-30 | 49.64K shares 10-Q · filed 2025-11-03 |
| 2025-06-30 | 1.50M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 48.50K shares 10-Q · filed 2025-05-13 |
| 2024-09-30 | 175.28K shares 10-Q · filed 2024-11-01 |
| 2024-06-30 | 430.61K shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 430.61K shares 10-Q · filed 2024-05-08 |
| 2023-09-30 | 309.01K shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 476.30K shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 476.30K shares 10-Q · filed 2023-05-11 |
| 2022-09-30 | 100.14K shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 195.43K shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 195.43K shares 10-Q · filed 2022-05-11 |
| 2021-08-31 | 338.11K shares 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |